MCRB
Seres Therapeutics Inc
2.60$
-3.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -149.4% | – | -766.8% | – | – | – | |
| – | -3.1% | -4.5% | -8.9% | -1.1% | -22.7% | -0.8% | -1.6% | -1.4% | -8.6% | -18.1% | -14.2% | – | |
| – | -41.4% | +27.6% | -14.7% | -6.3% | -27.4% | -25.1% | -17.0% | +6.1% | +28.9% | -44.8% | -1.5% | – | |
| – | – | – | – | – | -216.8% | – | – | -1,156.1% | – | – | – | – | |
| – | -51.2% | -92.9% | +59.7% | +30.3% | -30.2% | -62.2% | +432.4% | -95.6% | +262.5% | -100.0% | – | – | |
| – | -51.2% | -92.9% | – | +10,740.5% | -100.1% | -62.2% | +432.4% | -95.6% | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | +345.5% | +191.8% | -100.0% | – | – | -32.1% | -100.0% | – | +20,649.2% | -96.6% | +300.7% | – | |
| – | – | – | – | – | – | – | -148.0% | – | -182.9% | – | – | – | |
| – | – | – | – | – | – | – | -150.1% | – | -770.6% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.